Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan A Wilcox

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
American Journal of Hematology|September 27, 2015
A three-signal model of T-cell lymphoma pathogenesisRyan A Wilcox
American Journal of Hematology|July 25, 2018
Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and managementRyan A Wilcox
American Journal of Hematology|September 12, 2020
Janus Family kinase (JAK) inhibitors in HLH and severe COVID-19Ryan A Wilcox
Blood|February 3, 2022
Getting ALK inhibitors SHPshapeRyan A Wilcox
Blood|March 21, 2015
Mogamulizumab: 2 birds, 1 stoneRyan A Wilcox
American Journal of Hematology|November 27, 2015
Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and managementRyan A Wilcox
The Lancet. Haematology|April 29, 2018
Optimising initial treatment for peripheral T-cell lymphoma: a tough nut to CHOPRyan A Wilcox
Blood|October 2, 2025
More than skin deepRyan A Wilcox
Mayo Clinic Proceedings|July 2, 2010
Cancer-associated myeloproliferation: old association, new therapeutic targetRyan A Wilcox
American Journal of Hematology|September 6, 2017
Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and managementRyan A Wilcox
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
American Journal of Hematology|September 27, 2015
A three-signal model of T-cell lymphoma pathogenesisRyan A Wilcox
American Journal of Hematology|July 25, 2018
Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and managementRyan A Wilcox
American Journal of Hematology|September 12, 2020
Janus Family kinase (JAK) inhibitors in HLH and severe COVID-19Ryan A Wilcox
Blood|February 3, 2022
Getting ALK inhibitors SHPshapeRyan A Wilcox
Blood|March 21, 2015
Mogamulizumab: 2 birds, 1 stoneRyan A Wilcox
American Journal of Hematology|November 27, 2015
Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and managementRyan A Wilcox
The Lancet. Haematology|April 29, 2018
Optimising initial treatment for peripheral T-cell lymphoma: a tough nut to CHOPRyan A Wilcox
Blood|October 2, 2025
More than skin deepRyan A Wilcox
Mayo Clinic Proceedings|July 2, 2010
Cancer-associated myeloproliferation: old association, new therapeutic targetRyan A Wilcox
American Journal of Hematology|September 6, 2017
Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and managementRyan A Wilcox
Pageof 10